The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> July 12, 2019

Interview with the President, Chairman and CEO: Quanterix Corporation (NASDAQ:QTRX)

Hrusovsky, Kevin
Kevin Hrusovsky is President, Chairman and Chief Executive Officer of Quanterix Corporation. Mr. Hrusovsky is an American biotech entrepreneur, engineer and health care visionary. As part of his lead role at Quanterix Corporation, in 2016, Mr. Hrusovsky founded Powering Precision Health, an annual summit on advancing the deep science that powers precision health. Mr. Hrusovsky has been recognized with many awards, including a 2017 BBJ Innovation All-Star award. He is a three-time Award Finalist of the EY Entrepreneur of the Year — 2007, 2017 and 2018 — and received the Lifetime Achievement Award for Leadership in 2018 and E.G. Bailey Entrepreneurship Award in 2013, both from The Ohio State University. In 2015, Mr. Hrusovsky was named a BostInno’s 50 on Fire Awards Finalist in Healthcare and Medicine. In 2017, he took Quanterix public. Prior to joining Quanterix, he was President of Life Sciences and Technologies at PerkinElmer; CEO of Caliper Life Sciences, now PerkinElmer; and CEO of Zymark Corporation, now PerkinElmer. Previously, he served as President of FMC Corporation’s pharmaceuticals and head of international agricultural products and held key management positions at E.I. DuPont de Nemours. Mr. Hrusovsky holds an MBA from Ohio University and a B.S. in mechanical engineering from The Ohio State University. He received an honorary doctorate from Framingham State University for his contributions in life sciences and personal medicine. In addition, he helped build the competitive strategy curriculum at the Institute for Strategy & Competitiveness at Harvard Business School. Profile
Word count: 4,690

TWST: What is the company’s core technology, and how you would position it against the most common alternatives?

Mr. Hrusovsky: It is

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
Interview with the Co-CEO and the CAO: Planet 13 Holdings Inc. (OTCMKTS:PLNH)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy